In the present study, we show that cancer differentiation inducer CGA could reduce the expression of PD-L1 in cancer cells, thus protect tumor-infiltrated T cells from the PD-1/PD-L1 interaction caused T-cell death and so, enhance the therapeutic effect of the anti-PD-1 antibody. The gene discussed is PDCD1; the disease is neoplasm.